Description

Butenafine Hydrochloride is contraindicated in individuals who have known or suspected sensitivity to this cream or any of its components.

Rarely local mild burning or irritation may be experienced. Hypersensitivity reactions may occur.

Pregnancy Category C. As no adequate and well-controlled studies have been conducted, this drug should be used during pregnancy only if clearly needed. It is not known if butenafine HCl is excreted in human milk. Caution should be exercised in prescribing butenafine HCl to a nursing woman.

Butenafine cream is not for ophthalmic, oral, or intravaginal use. This is for external use only. If irritation or sensitivity develops with the use of Butenafine cream, treatment should be discontinued and appropriate therapy instituted.

Safety and efficacy in pediatric patients below the age of 12 years have not been studied.

Overdosage of butenafine HCl in humans has not been reported to date.